n (%) | |
---|---|
Disclosure of financial relationships | 145 (89%) |
Of author(s) | 145 (89) |
Of author’s institution | 40 (25) |
Of author’s family member(s) | 17 (10) |
Not explicitly required | 18 (11) |
Of other | 1 (0) |
Types of financial disclosure | |
Stock ownership | 83 (51) |
Grant/research support | 73 (45) |
Direct employment | 73 (45) |
Serving as an advisor, consultant, or public advocate | 70 (43) |
Honoraria for speaking, writing, or reviewing on the topic discussed in the manuscript | 53 (33) |
Personal fees | 50 (31) |
Indirect financial support | 47 (29) |
Speaker bureaus or board membership | 37 (23) |
Royalties | 26 (16) |
Other type of financial COI | 4 (3) |
Required but did not specify which types of financial COI | 40 (25) |
Not required | 28 (17) |
Duration for which to disclose financial COI | |
Not specified | 142 (87) |
Yes, for the previous number of months | 20 (12) |
Yes, irrespective of timing (i.e., at any time) | 1 (1) |
Number of months of required duration (N = 20) | |
Within 12 months | 0 (0) |
12 months | 0 (0) |
24 months | 1 (5) |
36 months | 18 (90) |
4 years | 0 (0) |
5 years | 1 (5) |
> 5 years | 0 (0) |
Time frame for financial COI disclosure | |
Time of the submission | 11 (7) |
At the initiation of the study | 5 (3) |
Not specified | 4 (3) |
Required disclosure of financial COI in the near future | 12 (7) |
Required duration of financial COI outside submitted work | 1 (0) |
Explicitly required source of financial benefit | 64 (39) |
Required monetary value of financial benefit | |
Not required | 162 (100) |
Yes, irrespective of amount | 1 (0) |
Yes, for amounts above a specific value | 0 (0) |
Required disclosure of any patents | 63 (41) |